These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16401401)

  • 21. Effects of parenteral structured lipid emulsion on modulating the inflammatory response in rats undergoing a total gastrectomy.
    Lin MT; Yeh SL; Tsou SS; Wang MY; Chen WJ
    Nutrition; 2009 Jan; 25(1):115-21. PubMed ID: 18834719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion.
    Shi S; Chen H; Cui Y; Tang X
    Int J Pharm; 2009 May; 373(1-2):147-55. PubMed ID: 19429300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Lipid Emulsion on Stability of Ampicillin in Total Parenteral Nutrition.
    Stawny M; Gostyńska A; Dettlaff K; Jelińska A; Główka E; Ogrodowczyk M
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30845675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
    Tian LL; Tang X; He HB; Wang J
    Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of physical stability of all in one parenteral admixtures for pediatric home care with high electrolytes concentrations.
    Watrobska-Swietlikowska D; Szlagatys-Sidorkiewicz A; Łuszkiewicz K
    Nutr Hosp; 2014 Jan; 31(1):236-43. PubMed ID: 25561115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca2+ additive under clinical application circumstances.
    Télessy IG; Balogh J; Szabó B; Csempesz F; Zelkó R
    Nutr J; 2012 May; 11():32. PubMed ID: 22591808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the coalescence kinetics of fat emulsions in dependence on the amount of fat and age.
    Harnisch S; Schuhmann R; Harnisch JF; Müller RH
    Pharmazie; 2002 Jan; 57(1):54-8. PubMed ID: 11836933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compatibility of cyclosporine with fat emulsion.
    Jacobson PA; Maksym CJ; Landvay A; Weiner N; Whitmore R
    Am J Hosp Pharm; 1993 Apr; 50(4):687-90. PubMed ID: 8470685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term stability of lipid emulsions with parenteral nutrition solutions.
    Tannuri U; Sesso A; Coelho MC; Maksoud JG
    Nutrition; 1992; 8(2):98-100. PubMed ID: 1591460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Finding new solutions in pediatric parenteral admixtures: how to improve quality and to deal with shortages.
    Watrobska-Swietlikowska D; Kwidzynska A; Szlagatys-Sidorkiewicz A; Sznitowska M; Klek S
    Nutr Hosp; 2014 Jul; 30(1):84-93. PubMed ID: 25137266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on parenteral lipids and immune function: only smoke, or is there any fire?
    Wanten G
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):79-83. PubMed ID: 16477169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature.
    Kadam AN; Najlah M; Wan KW; Ahmed W; Crean SJ; Phoenix DA; Taylor KM; Elhissi AM
    Pharm Dev Technol; 2014 Dec; 19(8):999-1004. PubMed ID: 24093888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between Parenteral Lipid Emulsions and Container Surfaces.
    Gonyon T; Tomaso AE; Kotha P; Owen H; Patel D; Carter PW; Cronin J; Green JB
    PDA J Pharm Sci Technol; 2013; 67(3):247-54. PubMed ID: 23752751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the intravenous lipid emulsions on the availability of calcium when using organic phosphate in TPN admixtures.
    Chaieb D S; Chaumeil JC; Jebnoun S; Khrouf N; Hedhili A; Sfar S
    Pharm Res; 2008 Nov; 25(11):2545-54. PubMed ID: 18719980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ["All in one" parenteral nutrition: is it that safe?].
    Gomis P; Sevilla E; Oliver MJ; Moreno JM; León M; Montejo JC; Santos-Ruiz MA; Armentia L; Herreros de Tejada A
    Nutr Hosp; 1994; 9(5):316-23. PubMed ID: 7986855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicochemical stability of two types of intravenous lipid emulsion as total nutrient admixtures.
    Driscoll DF; Bacon MN; Bistrian BR
    JPEN J Parenter Enteral Nutr; 2000; 24(1):15-22. PubMed ID: 10638467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effects of parenteral nutrition of cholestatic infants with lipid emulsions based on medium-chain and long-chain triacylglycerols.
    Socha P; Koletzko B; Demmelmair H; Jankowska I; Stajniak A; Bednarska-Makaruk M; Socha J
    Nutrition; 2007 Feb; 23(2):121-6. PubMed ID: 17234505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical stability of intravenous lipid emulsions as all-in-one admixtures intended for the very young.
    Driscoll DF; Nehne J; Peterss H; Klütsch K; Bistrian BR; Niemann W
    Clin Nutr; 2003 Oct; 22(5):489-95. PubMed ID: 14512037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological activity of recombinant interleukin-2 in intravenous admixtures containing antibiotic, morphine sulfate, or total parenteral nutrient solution.
    Anderson PM; Rogosheske JR; Ramsay NK; Weisdorf DJ
    Am J Hosp Pharm; 1992 Mar; 49(3):608-12. PubMed ID: 1598936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid peroxidation in all-in-one admixtures for preterm neonates: impact of amount of lipid, type of lipid emulsion and delivery condition.
    Jalabert A; Grand A; Steghens JP; Barbotte E; Pigue C; Picaud JC
    Acta Paediatr; 2011 Sep; 100(9):1200-5. PubMed ID: 21418099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.